Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.
Bioprosthetic heart valves (BHVs) derived from glutaraldehyde crosslinked porcine aortic valves are frequently used in heart valve replacement surgeries. However, BHVs have limited durability and fail either due to degeneration or calcification. Glycosaminoglycans (GAGs), one of the integral components of heart valve cuspal tissue, are not stabilized by conventional glutaraldehyde crosslinking. Previously we have shown that valvular GAGs could be chemically fixed with GAG-targeted chemistry. However, chemically stabilized GAGs were only partially stable to enzymatic degradation. In the present study an enzyme inhibitor was incorporated in the cusps to effectively prevent enzymatic degradation. Thus, neomycin trisulfate, a known hyaluronidase inhibitor, was incorporated in cusps via 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) chemistry followed by glutaraldehyde crosslinking (NEG). Controls included cusps crosslinked with either EDC/NHS followed by glutaraldehyde (ENG) or only with glutaraldehyde (GLUT). NEG group showed improved resistance to in vitro enzymatic degradation as compared to GLUT and ENG groups. All groups showed similar collagen stability, measured as a thermal denaturation temperature by differential scanning calorimetry (DSC). The cusps were implanted subdermally in rats to study in vivo degradation of GAGs. NEG group preserved significantly more GAGs than ENG and GLUT. NEG and ENG groups showed reduced calcification than GLUT.
Raghavan
Devanathan
D
Cardiovascular Implant Research Laboratory (CIRL), Department of Bioengineering, Clemson University, 401 Rhodes Engineering Center, Clemson, SC 29634, USA.
Simionescu
Dan T
DT
Vyavahare
Naren R
NR
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002152:Calorimetry, Differential Scanning; D003094:Collagen / Q000378:metabolism; D004586:Electrophoresis; D005976:Glutaral / Q000737:chemistry; D006025:Glycosaminoglycans / Q000737:chemistry / Q000378:metabolism*; D006350:Heart Valve Prosthesis; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007150:Immunohistochemistry; D009355:Neomycin / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D013552:Swine; D013696:Temperature
D006025:Glycosaminoglycans; D003094:Collagen; D006821:Hyaluronoglucosaminidase; D009355:Neomycin; D002118:Calcium; D005976:Glutaral